Insights Articles
Article
FDA Leaders Propose New “Plausible Mechanism Pathway” for Development and Approval of Drugs and Biologics
November 20, 2025
| Thomson Reuters Westlaw Today
Authors:
Person Beverly Lorell
Bev H. Lorell, M.D. (Beverly)
Consultant
Person Christina Markus
Christina M. Markus (Chris)
Partner
Person Dennis Sampson
D. Kyle Sampson
Partner
Person Lauren Roth
Lauren K. Roth
Partner

Go to the article

Authors
Person Beverly Lorell
Bev H. Lorell, M.D. (Beverly)
Consultant
Government Matters & Regulation
Person Christina Markus
Christina M. Markus (Chris)
Partner
Government Matters & Regulation
Person Dennis Sampson
D. Kyle Sampson
Partner
Government Matters & Regulation
Person Lauren Roth
Lauren K. Roth
Partner
Government Matters & Regulation
Related Capabilities
FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
FDA & Life Sciences
Learn More

The Best and Latest Insights
All in One Place.

Subscribe